Primary hyperoxaluria Clinical Trials

• Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria
  ClinicalTrials.gov Identifier: NCT00280215 - Recruiting
  Hyperoxaluria
  
• Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria
  ClinicalTrials.gov Identifier: NCT00283387 - Recruiting
  Hyperoxaluria
  
• A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria
  ClinicalTrials.gov Identifier: NCT00490113 - Recruiting
  Kidney Stones
  
• Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
  ClinicalTrials.gov Identifier: NCT00022178 - Active, not recruiting
  squamous cell carcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; undifferentiated carcinoma of unknown primary; ...
  
• Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
  ClinicalTrials.gov Identifier: NCT00003907 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00066781 - Active, not recruiting
  adenocarcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; squamous cell carcinoma of unknown primary; ...
  
• Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00003558 - Active, not recruiting
  adenocarcinoma of unknown primary; newly diagnosed carcinoma of unknown primary
  
• DX-8951f in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00004108 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00040898 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Doxorubicin and Bortezomib in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00083226 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Gemcitabine, Docetaxel, and Capecitabine in Treating Patients with Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00119314 - Active, not recruiting
  newly diagnosed carcinoma of unknown primary; recurrent carcinoma of unknown primary
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00005629 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003714 - Active, not recruiting
  advanced adult primary liver cancer; liver metastases; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00022334 - Active, not recruiting
  localized resectable adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
  
• Oxaliplatin in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00052364 - Active, not recruiting
  advanced adult primary liver cancer; localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00020774 - Active, not recruiting
  recurrent adult primary liver cancer; localized resectable adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
  ClinicalTrials.gov Identifier: NCT00047125 - Active, not recruiting
  newly diagnosed carcinoma of unknown primary; squamous cell carcinoma of unknown primary
  
• Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00109954 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00006010 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00077142 - Active, not recruiting
  advanced adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00077441 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Proteomic Study of Urinary Stone Disease
  ClinicalTrials.gov Identifier: NCT00199459 - Recruiting
  Urinary Calculi; Hyperoxaluria; Calculi
  
• Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00003929 - Active, not recruiting
  AIDS-related primary CNS lymphoma; primary central nervous system lymphoma
  
• AZD2171 in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00238394 - Active, not recruiting
  Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer
  
• Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00041275 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00071994 - Active, not recruiting
  advanced adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• Adult Primary Insomnia Polysomnographic Study
  ClinicalTrials.gov Identifier: NCT00094627 - Active, not recruiting
  Primary Insomnia
  
• Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00047229 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00055692 - Active, not recruiting
  adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized unresectable adult primary liver cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00003061 - Active, not recruiting
  primary central nervous system lymphoma
  
• Tamoxifen in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003424 - Active, not recruiting
  advanced adult primary liver cancer; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer; Quality of Life
  
• Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma Cancer
  ClinicalTrials.gov Identifier: NCT00057980 - Active, not recruiting
  advanced adult primary liver cancer; localized unresectable adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00004248 - Active, not recruiting
  recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• T900607 in Treating Patients With Unresectable Liver Cancer
  ClinicalTrials.gov Identifier: NCT00054262 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Doxorubicin With or Without Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00079027 - Active, not recruiting
  advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00004136 - Active, not recruiting
  recurrent adult primary liver cancer; stage III childhood liver cancer; liver metastases; advanced adult primary liver cancer; ...
  
• Gene Therapy in Treating Patients With Cancer of The Liver
  ClinicalTrials.gov Identifier: NCT00003147 - Active, not recruiting
  adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00003632 - Active, not recruiting
  primary central nervous system lymphoma
  
• Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00193973 - Active, not recruiting
  Primary Central Nervous System Lymphoma
  
• Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193622 - Active, not recruiting
  Neoplasms, Unknown Primary
  
• Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00357630 - Active, not recruiting
  Carcinoma of Unknown Primary; Pain
  
• Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer
  ClinicalTrials.gov Identifier: NCT00027768 - Active, not recruiting
  localized resectable adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Gemox as First and Second Line Therapy in Unknown Primary Cancer
  ClinicalTrials.gov Identifier: NCT00353145 - Active, not recruiting
  Unknown Primary Neoplasms
  
• MK0928 Study in Adult Patients With Primary Insomnia
  ClinicalTrials.gov Identifier: NCT00266344 - Active, not recruiting
  Primary Insomnia
  
• Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial
  ClinicalTrials.gov Identifier: NCT00522028 - Active, not recruiting
  Primary Hyperparathyroidism
  
• Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
  ClinicalTrials.gov Identifier: NCT00132041 - Active, not recruiting
  adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003530 - Active, not recruiting
  stage IV childhood liver cancer; recurrent childhood liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer
  
• Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
  ClinicalTrials.gov Identifier: NCT00081094 - Active, not recruiting
  adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized resectable adult primary liver cancer
  
• Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
  ClinicalTrials.gov Identifier: NCT00003296 - Active, not recruiting
  recurrent adult primary liver cancer; localized gallbladder cancer; advanced adult primary liver cancer; cholangiocarcinoma of the gallbladder; ...
  
• Prepubertal Children with Growth Failure Associated with Primary IGF-1 Deficiency
  ClinicalTrials.gov Identifier: NCT00125164 - Active, not recruiting
  Insulin-Like Growth Factor-1 Deficiency; Primary IGF-1 Deficiency
  
• A 6-Week Open Label Cross-Over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)
  ClinicalTrials.gov Identifier: NCT00209261 - Active, not recruiting
  Primary Nocturnal Enuresis
  
• Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00003526 - Recruiting
  adenocarcinoma of unknown primary; recurrent carcinoma of unknown primary
  
• Hepatic Arterial Infusion Plus Internal Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00039078 - Recruiting
  localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00009893 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; recurrent gallbladder cancer; unresectable gallbladder cancer; ...
  
• Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00532285 - Active, not recruiting
  Breast Cancer; Primary
  
• Dexamethasone Plus Interferon alfa in Treating Patients With Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00002849 - Active, not recruiting
  primary systemic amyloidosis
  
• Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003278 - Active, not recruiting
  primary central nervous system lymphoma; intraocular lymphoma
  
• Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00128596 - Recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer
  
• Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
  ClinicalTrials.gov Identifier: NCT00049322 - Recruiting
  localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Treatment of Primary Menstrual Pain With Kanion Capsule
  ClinicalTrials.gov Identifier: NCT00523146 - Recruiting
  Primary Dysmenorrhea
  
• 4'-Iodo-4'-deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00003853 - Active, not recruiting
  primary systemic amyloidosis
  
• Sleep Homeostasis in Primary Insomnia Following Behavioral Treatment
  ClinicalTrials.gov Identifier: NCT00256503 - Recruiting
  Primary Insomnia
  
• Immunotherapy Combined With Chemotherapy Followed by Radiation Therapy and Chemotherapy in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00059956 - Active, not recruiting
  primary central nervous system lymphoma
  
• Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00003557 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; cholangiocarcinoma of the gallbladder; ...
  
• Treatment for Depression in the Primary Care Setting
  ClinicalTrials.gov Identifier: NCT00055328 - Active, not recruiting
  Depression
  
• Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00074191 - Active, not recruiting
  intraocular lymphoma; primary central nervous system lymphoma
  
• Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00074178 - Active, not recruiting
  primary central nervous system lymphoma; intraocular lymphoma
  
• Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer
  ClinicalTrials.gov Identifier: NCT00030511 - Active, not recruiting
  localized resectable adult primary liver cancer; recurrent adult primary liver cancer; localized extrahepatic bile duct cancer; ...
  
• Preventive Primary Care Outreach for High Risk Older Persons
  ClinicalTrials.gov Identifier: NCT00134836 - Active, not recruiting
  Frailty
  
• Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00089167 - Active, not recruiting
  primary systemic amyloidosis
  
• Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis
  ClinicalTrials.gov Identifier: NCT00075621 - Active, not recruiting
  primary systemic amyloidosis
  
• Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00360360 - Recruiting
  Neoplasm, Unknown Primary
  
• Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00052884 - Active, not recruiting
  Drug Toxicity; primary systemic amyloidosis
  
• Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts
  ClinicalTrials.gov Identifier: NCT00374647 - Recruiting
  Primary Renal Allograft
  
• Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery
  ClinicalTrials.gov Identifier: NCT00571155 - Recruiting
  Primary Brain Tumor; Epilepsy
  
• Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193609 - Recruiting
  Neoplasms, Unknown Primary
  
• Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis
  ClinicalTrials.gov Identifier: NCT00447915 - Recruiting
  Primary Osteoporosis
  
• A Dose-Ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia
  ClinicalTrials.gov Identifier: NCT00551148 - Recruiting
  Primary Insomnia
  
• Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients
  ClinicalTrials.gov Identifier: NCT00397189 - Recruiting
  Primary Insomnia
  
• Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism
  ClinicalTrials.gov Identifier: NCT00173082 - Recruiting
  Primary Aldosteronism, OGTT
  
• Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia
  ClinicalTrials.gov Identifier: NCT00415714 - Recruiting
  Primary Insomnia
  
• VEC-162 Study in Adult Patients With Primary Insomnia
  ClinicalTrials.gov Identifier: NCT00548340 - Recruiting
  Primary Insomnia
  
• PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors
  ClinicalTrials.gov Identifier: NCT00269373 - Recruiting
  Unknown Primary Tumor
  
• Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00059865 - Active, not recruiting
  advanced adult primary liver cancer; unresectable gallbladder cancer; unresectable extrahepatic bile duct cancer; ...
  
• Chemotherapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003044 - Active, not recruiting
  localized unresectable adult primary liver cancer
  
• Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00109798 - Recruiting
  primary central nervous system lymphoma
  
• Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00004005 - Active, not recruiting
  adult solid tumor; carcinoma of unknown primary; childhood solid tumor; Colon Cancer; Rectal Cancer
  
• Preventing Adverse Drug Events with PatientSite
  ClinicalTrials.gov Identifier: NCT00140504 - Active, not recruiting
  Preventive health; Primary care; Adverse drug event
  
• Nasal Potential Difference (NPD) Testing: Evaluation of CFTR Function in Children With Primary Sclerosing Cholangitis (PSC)
  ClinicalTrials.gov Identifier: NCT00179439 - Recruiting
  Primary Sclerosing Cholangitis; Inflammatory Bowel Disease
  
• Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193596 - Recruiting
  Neoplasms, Unknown Primary
  
• Testing the Nocturnal Sleep Latency Profile in Primary Insomnia
  ClinicalTrials.gov Identifier: NCT00167375 - Recruiting
  Primary Insomnia; Sleep Initiation and Maintenance Disorders
  
• Whole Brain Irradiation in Primary CNS Lymphoma (PCNSL)
  ClinicalTrials.gov Identifier: NCT00153530 - Recruiting
  Primary Central Nervous System Lymphoma
  
• Phase II Study of Modified Triple Doublet Therapy in Women with Newly Diagnosed Mullerian Carcinoma
  ClinicalTrials.gov Identifier: NCT00157560 - Active, not recruiting
  Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
  
• Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients
  ClinicalTrials.gov Identifier: NCT00574353 - Recruiting
  Primary Rectal Cancer
  
• Evaluating Progression of and Diagnostic Tools for Primary Ciliary Dyskinesia in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00450918 - Recruiting
  Primary Ciliary Dyskinesia
  
• Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00003261 - Recruiting
  AIDS-related primary CNS lymphoma
  
• Probiotics in Patients with Primary Sclerosing Cholangitis
  ClinicalTrials.gov Identifier: NCT00161148 - Recruiting
  Primary Sclerosing Cholangitis
  
• The Effects of MODafinil on Waking Function and on Sleep in Individuals with Promary Insomnia
  ClinicalTrials.gov Identifier: NCT00124384 - Recruiting
  Primary Insomnia
  
• Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00248534 - Recruiting
  Primary Central Nervous System Lymphoma
  
• Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)
  ClinicalTrials.gov Identifier: NCT00145964 - Recruiting
  Liver Cirrhosis, Biliary; Biliary Cirrhosis, Primary